Tempus AI (TEM) has seen a significant surge on Wednesday, with its stock climbing 14.62% in just one day. The significant boost in TEM stock ...

Tempus stands to earn $200 million in data licensing and model development fees from the collaborations, the release said.

(RTTNews) - Illumina Inc. (ILMN) and Tempus AI, Inc. (TEM), Tuesday announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation.

Illumina is teaming up with Tempus AI for a project aimed at promoting the use of DNA sequencing tests across all major areas of disease. The companies said they will work together to train ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Whether you’re a recent graduate, a mid-career professional seeking a change, or an executive looking to enhance leadership skills, a career coach can be an invaluable resource. A 2021 Harris ...

Financial giants have made a conspicuous bullish move on Tempus AI. Our analysis of options history for Tempus AI TEM revealed 15 unusual trades. Delving into the details, we found 53% of traders ...

BofA lowered the firm’s price target on Tempus AI (TEM) to $48 from $60 and keeps a Neutral rating on the shares. Sentiment for Life Sciences and Diagnostic Tools and Contract Research ...

Artificial intelligence (AI) is rapidly being integrated into every domain of healthcare, giving birth to a new class of tech-driven innovators. Tempus AI TEM and Doximity DOCS stand out as ...

On Thursday, Cathie Wood-led Ark Invest made notable trades, prominently featuring Tempus AI and Coinbase Global. The trades came as Wall Street reversed Wednesday's rally with a sharp selloff ...